Hypoxic preconditioning - A nonpharmacological approach in COVID-19 prevention.
Ontology highlight
ABSTRACT: Hypoxia is defined by low oxygen concentration in organs, tissues, and cells. Maintaining oxygen homeostasis represents the essential cellular metabolic process for the structural integrity of tissues in different pathological conditions, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Considering the role of hypoxia-inducible factor-1 as the regulator of cellular response to hypoxia and its involvement in angiogenesis, erythropoiesis, glucose metabolism, inflammation, we propose hypoxic preconditioning (HPC) as a novel prevention therapeutic approach on healthy contacts of patients with coronavirus disease-2019 (COVID-19). To date, several studies revealed the beneficial effects of HPC in ischemia, kidney failure, and in pulmonary function recovery of pat
SUBMITTER: Hertzog RG
PROVIDER: S-EPMC7690942 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA